The first cohort (study group) contained patients with a diagnosis of MASLD/MASH who received any GLP-1 agonist after the first instance of diagnosis (i.e., MASLD/MASH)
One of the primary outcomes assessed was motor coordination and balance using the rotarod test
The STEP clinical trials, which evaluated semaglutide for chronic weight management in adults without diabetes, recorded fatigue and sleepiness as mild to moderate adverse events
Buch A, Carmeli E, Boker LK, Marcus Y, Shefer G, Kis O, et al
New pharmacological treatments for obesity: incretin analogues, their mechanism of action, efficacy and safety Incretin analogues are very effective weight loss medications resulting in weight loss approaching that achieved with bariatric surgery
Injection Process 1